FANDOM


History

Jonathan Crane

Missing Data

Scarecrow

Missing Data

Threat Assessment

Missing Data

Arkham Files

Medical Profile

  • Patient is in good physical health.
  • Patient's blood tests show he has built up a considerate resistance to his so-called "Fear Toxin" from repeated exposure.
  • Patient is currently under investigation by for the murder of his grandmother using a homemade pest control chemical.

Psychological Profile

  • Patient has advanced "Phobophilia" or love of fear. Patient is so desensitized to fear that he is compelled to cause fear in others as a form of transference.

Behavior Profile

  • Patient is a former employee of Arkham Asylum (Head of Research - 9 years) and was the supervisor of Dr. Hugo Strange. The two created a psychotropic medication which Crane later developed into his "Fear Gas".
  • Patient is a cunning sociopathic genius. Do not underestimate him.
  • Patient may engage in psychoanalysis of others in an attempt to deduce their darkest fear or torment them... he is highly effective at such cruelty.
  • Patient's therapy is postponed after the suicides of his last two therapist.
  • Patient has an extensive criminal history with a large number of accomplices who now reside here in Arkham as patients.
  • Patient's cell should be searched daily for homemade masks.
  • Threat Assignment: High
  • Treatment Ranking: 4-Resistant
  • Intake Interviewer: Dr. Roy Westerman
  • Assigned Patient Coordinator: Dr. Roy Westerman[1]

Trivia and Notes

Trivia

  • When he's in Arkham he's housed in the Intensive Care Area.
  • In addition to creating the "Fear Toxin" he also made a drug called "Content" (or "Bliss") used in Spyral brainwashing.[2]

Notes

  • Scarecrow's Patient number (#61505) is a nod to his appearance in Batman Begins on June 15th 2005.
  • Scarecrow's needle-glove is a nod to Nightmare on Elm Street and Batman: Arkham games.
  • The "Content" drug might be a nod to Gothtopia.

Links and References

  1. Arkham Files: Scarecrow
  2. VOX Box: Heretic Saga 26
Community content is available under CC-BY-SA unless otherwise noted.